Early diagnosis of tumors
Provide effective solutions
VEGF detection can be used for early broad-spectrum screening of tumors in healthy people, and can monitor the effect of tumor patients after surgery and after comprehensive treatment.
ExploreProducts
Vascular endothelial growth factor (VEGF) assay kit (magnetic particle luminescence method), Platelet activation detection reagent (flow cytometry), Lymphocyte subgroup detection reagent (flow cytometry), Sperm function test series (flow cytometry)
Zhongyuan independently developed a new magnetic particle luminescence technology, which can be accurate to 5pg level, and the self-developed flow cell technology can carry out multi-parameter, rapid quantitative analysis and sorting one by one.
Tumor immunotherapy
Health Management
Early tumor screening
Ultra-early diagnosis of tumors (tumor-initiating cells), individualized tumor-initiating cell immunotherapy, individualized tumor animal chemotherapy and drug sensitivity testing, and tumor biopsy storage, etc.
Inflammation series detection
Ultra-early diagnosis of tumors (tumor-initiating cells), individualized tumor-initiating cell immunotherapy, individualized tumor animal chemotherapy and drug sensitivity testing, and tumor biopsy storage, etc.
Immunity assessment
Ultra-early diagnosis of tumors (tumor-initiating cells), individualized tumor-initiating cell immunotherapy, individualized tumor animal chemotherapy and drug sensitivity testing, and tumor biopsy storage, etc.
Platelet function
Ultra-early diagnosis of tumors (tumor-initiating cells), individualized tumor-initiating cell immunotherapy, individualized tumor animal chemotherapy and drug sensitivity testing, and tumor biopsy storage, etc.
Sperm function assessment
Ultra-early diagnosis of tumors (tumor-initiating cells), individualized tumor-initiating cell immunotherapy, individualized tumor animal chemotherapy and drug sensitivity testing, and tumor biopsy storage, etc.
Technology Platform
Immunomagnetic particle luminescence platform
Tumor Detection, Inflammation Detection
Technology Platform
The team's new research technology on tumor-initiating (stem) cells has gradually transformed into applied technologies for early diagnosis and prognosis of tumors, and has applied for a number of patents related to early diagnosis and treatment of tumors.
Customer Service
Equipment maintenance and reagent related issues
Equipment failure problem, reagent quality problem, service quality problem, market expansion problem...
Leave us a messageNews
Understand the real-time information and industry dynamics of Zhongyuan
Ultra-early diagnosis of tumors (tumor-initiating cells), individualized tumor-initiating cell immunotherapy, individualized tumor animal chemotherapy and drug sensitivity testing, and tumor biopsy storage, etc.
Ningbo Zhongyuan Biotechnology Co., Ltd.
15th Floor, Block A, 89 Cuibai Road, Haishu District, Ningbo City
Tel:+86 0574-87206227,+86 13905845087
Email:1409244836@qq.com
Guizhou Zhongyuan Biotechnology Co., Ltd.
11/F, Building B4, Zhihui Yunjin, No.2, Happy North Road, Wudang District, Guiyang City, Guizhou Province
Guizhou Zhongyuan Medical Technology Co., Ltd.
11/F, Building B4, Zhihui Yunjin, No.2, Happy North Road, Wudang District, Guiyang City, Guizhou Province